Works by Alanen, Kalle

Results: 24

The same endothelial receptor controls lymphocyte traffic both in vascular and lymphatic vessels.

Published in:

European Journal of Immunology, 2003, v. 33, n. 3, p. 815, doi. 10.1002/eji.200323859

By:

Irjala, Heikki;
Elima, Kati;
Johansson, Eva-Liz;
Merinen, Marika;
Kontula, Keiju;
Alanen, Kalle;
Grenman, Reidar;
Salmi, Marko;
Jalkanen, Sirpa

Publication type:

Article

Activating mutation (V617F) in the tyrosine kinase JAK2 is absent in locally-confined or castration-resistant prostate cancer.

Published in:

Analytical Cellular Pathology: Cellular Oncology, 2010, v. 33, n. 2, p. 55, doi. 10.1155/2010/610974

By:

Lei Gu;
Xian-Hua Zhu;
Visakorpi, Tapio;
Alanen, Kalle;
Mirtti, Tuomas;
Edmonston, Tina Bocker;
Nevalainen, Marja T.

Publication type:

Article

Increased Expression and Altered Cellular Localization of Fibroblast Growth Factor Receptor-Like 1 (FGFRL1) Are Associated with Prostate Cancer Progression.

Published in:

Cancers, 2022, v. 14, n. 2, p. 278, doi. 10.3390/cancers14020278

By:

Yu, Lan;
Toriseva, Mervi;
Afshan, Syeda;
Cangiano, Mario;
Fey, Vidal;
Erickson, Andrew;
Seikkula, Heikki;
Alanen, Kalle;
Taimen, Pekka;
Ettala, Otto;
Nurmi, Martti;
Boström, Peter J.;
Kallajoki, Markku;
Tuomela, Johanna;
Mirtti, Tuomas;
Beumer, Inès J.;
Nees, Matthias;
Härkönen, Pirkko

Publication type:

Article

Metabolic Imaging of Ovarian Tumors with Carbon-11-Methionine: A PET Study.

Published in:

Journal of Nuclear Medicine, 1995, v. 36, n. 12, p. 2196

By:

Lapela, Maria;
Leskinen-Kallio, Sirkku;
Varpula, Matti;
Grénman, Seija;
Salmi, Tuula;
Alanen, Kalle;
Någren, Kjell;
Lehikoinen, Pertti;
Ruotsalainen, Ulla;
Teräs, Mika;
Joensuu, Heikki

Publication type:

Article

Imaging of Uterine Carcinoma by Carbon-11-Methionine and PET.

Published in:

Journal of Nuclear Medicine, 1994, v. 35, n. 10, p. 1618

By:

Lapela, Maria;
Leskinen-Kallio, Sirkku;
Varpula, Matti;
Grenman, Seija;
Alanen, Kalle;
Någren, Kjell;
Lehikoinen, Pertti;
Ruotsalainen, Ulla;
Teräs, Mika;
Joensuu, Heikki

Publication type:

Article

Group IIA phospholipase A2 as a prognostic marker in prostate cancer: relevance to clinicopathological variables and disease-specific mortality.

Published in:

APMIS, 2009, v. 117, n. 3, p. 151, doi. 10.1111/j.1600-0463.2008.00002.x

By:

MIRTTI, TUOMAS;
LAINE, VELI JUKKA O.;
HIEKKANEN, HEIKKI;
HURME, SAIJA;
ROWE, OUTI;
NEVALAINEN, TIMO J.;
KALLAJOKI, MARKKU;
ALANEN, KALLE

Publication type:

Article

Altered expression of syndecan-1 in prostate cancer.

Published in:

APMIS, 2004, v. 112, n. 2, p. 89, doi. 10.1111/j.1600-0463.2004.apm1120202.x

By:

Kiviniemi, Johanna;
Kallajoki, Markku;
Kujala, Iina;
Matikainen, Marja-Terttu;
Alanen, Kalle;
Jalkanen, Markku;
Salmivirta, Markku

Publication type:

Article

Elevated Group II Phospholipase A2 Mass Concentration in Serum and Colonic Mucosa in Crohn's Disease.

Published in:

Clinical Chemistry & Laboratory Medicine, 1998, v. 36, n. 10, p. 751

By:

Haapamäki, Markku M.;
Grönroos, Juha M.;
Nurmi, Heimo;
Söderlund, Kristiina;
Peuravuori, Heikki;
Alanen, Kalle;
Nevalainen, Timo J.

Publication type:

Article

Desmocollin expression in oral atrophic lichen planus correlates with clinical behavior and DNA content.

Published in:

Journal of Cutaneous Pathology, 2008, v. 35, n. 9, p. 832, doi. 10.1111/j.1600-0560.2007.00903.x

By:

Mattila, Riikka;
Alanen, Kalle;
Syrjänen, Stina

Publication type:

Article

Regulation of prostate cell collagen receptors by malignant transformation.

Published in:

International Journal of Cancer, 2006, v. 118, n. 4, p. 889, doi. 10.1002/ijc.21430

By:

Mirtti, Tuomas;
Nylund, Camilla;
Lehtonen, Janika;
Hiekkanen, Heikki;
Nissinen, Liisa;
Kallajoki, Markku;
Alanen, Kalle;
Gullberg, Donald;
Heino, Jyrki

Publication type:

Article

Accuracy of 18F-FDG PET/CT, Multidetector CT, and MR Imaging in the Diagnosis of Pancreatic Cysts: A Prospective Single-Center Study.

Published in:

Journal of Nuclear Medicine, 2015, v. 56, n. 8, p. 1163, doi. 10.2967/jnumed.114.148940

By:

Kauhanen, Saila;
Rinta-Kiikka, Irina;
Kemppainen, Jukka;
Grönroos, Juha;
Kajander, Sami;
Seppänen, Marko;
Alanen, Kalle;
Gullichsen, Risto;
Nuutila, Pirjo;
Ovaska, Jari

Publication type:

Article

Functional Imaging of Localized Prostate Cancer Aggressiveness Using 11C-Acetate PET/CT and 11H-MR Spectroscopy.

Published in:

Journal of Nuclear Medicine, 2010, v. 51, n. 11, p. 1676, doi. 10.2967/jnumed.110.078667

By:

Jambor, Ivan;
Borra, Ronald;
Kemppainen, Jukka;
Lepomäki, Virva;
Parkkola, Riitta;
Dean, Kirsti;
Alanen, Kalle;
Arponen, Eveliina;
Nurmi, Martti;
Aronen, Hannu J.;
Minn, Heikki

Publication type:

Article

Prebiopsy multiparametric 3T prostate MRI in patients with elevated PSA, normal digital rectal examination, and no previous biopsy.

Published in:

Journal of Magnetic Resonance Imaging, 2015, v. 41, n. 5, p. 1394, doi. 10.1002/jmri.24682

By:

Jambor, Ivan;
Kähkönen, Esa;
Taimen, Pekka;
Merisaari, Harri;
Saunavaara, Jani;
Alanen, Kalle;
Obsitnik, Branislav;
Minn, Heikki;
Lehotska, Viera;
Aronen, Hannu J.

Publication type:

Article

Effect of DNA ploidy classification on prognosis in breast cancer.

Published in:

International Journal of Cancer, 1992, v. 52, n. 5, p. 701, doi. 10.1002/ijc.2910520506

By:

Joensuu, Heikki;
Alanen, Kalle;
Falkmer, Ursula G.;
Klemi, Pekka;
Nordling, Stig;
Remvikos, Yorghos;
Toikkanen, Sakari

Publication type:

Article

Expression of cystatins, high molecular weight cytokeratin, and proliferation markers in prostatic adenocarcinoma and hyperplasia.

Published in:

Prostate, 2003, v. 54, n. 4, p. 290, doi. 10.1002/pros.10196

By:

Mirtti, Tuomas;
Alanen, Kalle;
Kallajoki, Markku;
Rinne, Ari;
Söderström, Karl-Ove

Publication type:

Article

Increased expression of fibroblast growth factor 13 in prostate cancer is associated with shortened time to biochemical recurrence after radical prostatectomy.

Published in:

International Journal of Cancer, 2016, v. 139, n. 1, p. 140, doi. 10.1002/ijc.30048

By:

Yu, Lan;
Toriseva, Mervi;
Tuomala, Miikka;
Seikkula, Heikki;
Elo, Teresa;
Tuomela, Johanna;
Kallajoki, Markku;
Mirtti, Tuomas;
Taimen, Pekka;
Boström, Peter J.;
Alanen, Kalle;
Nurmi, Martti;
Nees, Matthias;
Härkönen, Pirkko

Publication type:

Article

Androgen receptor-interacting protein HSPBAP1 facilitates growth of prostate cancer cells in androgen-deficient conditions.

Published in:

International Journal of Cancer, 2015, v. 136, n. 11, p. 2535, doi. 10.1002/ijc.29303

By:

Saeed, Khalid;
Östling, Päivi;
Björkman, Mari;
Mirtti, Tuomas;
Alanen, Kalle;
Vesterinen, Tiina;
Sankila, Anna;
Lundin, Johan;
Lundin, Mikael;
Rannikko, Antti;
Nordling, Stig;
Mpindi, John‐Patrick;
Kohonen, Pekka;
Iljin, Kristiina;
Kallioniemi, Olli;
Rantala, Juha K.

Publication type:

Article

Detection of melanoma-derived cancer-testis antigen CT16 in patient sera by a novel immunoassay.

Published in:

International Journal of Cancer, 2011, v. 128, n. 10, p. 2382, doi. 10.1002/ijc.25571

By:

Rappu, Pekka;
Nylund, Camilla;
Ristiniemi, Noora;
Kulpakko, Janne;
Vihinen, Pia;
Hernberg, Micaela;
Mirtti, Tuomas;
Alanen, Kalle;
Kallajoki, Markku;
Vuoristo, Meri-Sisko;
Pyrhönen, Seppo;
Heino, Jyrki

Publication type:

Article

Cell Proliferation in Dimethylbenz(A)Anthracene(Dmba)- Induced rat Mammary Carcinoma Treated with Antiestrogen Toremifene.

Published in:

Acta Oncologica, 1995, v. 34, n. 4, p. 479, doi. 10.3109/02841869509094011

By:

Huovinen, Riikka L.;
Alanen, Kalle A.;
Collan, YrjÖ U.

Publication type:

Article

High-Throughput Transcriptomic and RNAi Analysis Identifies AIM1, ERGIC1, TMED3 and TPX2 as Potential Drug Targets in Prostate Cancer.

Published in:

PLoS ONE, 2012, v. 7, n. 6, p. 1, doi. 10.1371/journal.pone.0039801

By:

Vainio, Paula;
Mpindi, John-Patrick;
Kohonen, Pekka;
Fey, Vidal;
Mirtti, Tuomas;
Alanen, Kalle A.;
Perälä, Merja;
Kallioniemi, Olli;
Iljin, Kristiina

Publication type:

Article

Immunohistochemical study on topoisomerase IIα, Ki-67 and cytokeratin-19 in oral lichen planus lesions.

Published in:

Archives of Dermatological Research, 2007, v. 298, n. 8, p. 381, doi. 10.1007/s00403-006-0711-z

By:

Mattila, Riikka;
Alanen, Kalle;
Syrjänen, Stina

Publication type:

Article

Fluorine-18-L-dihydroxyphenylalanine (18F-DOPA) positron emission tomography as a tool to localize an insulinoma or β-cell hyperplasia in adult patients.

Published in:

Journal of Clinical Endocrinology & Metabolism, 2007, v. 92, n. 4, p. 1237, doi. 10.1210/jc.2006-1479

By:

Kauhanen, Saila;
Seppänen, Marko;
Minn, Heikki;
Gullichsen, Risto;
Salonen, Anna;
Alanen, Kalle;
Parkkola, Riitta;
Solin, Olof;
Bergman, Jörgen;
Sane, Timo;
Salmi, Jorma;
Välimäki, Matti;
Nuutila, Pirjo

Publication type:

Article

Uptake of [N-methyl-[sup 11] C]α-methylaminoisobutyric acid in untreated head and neck cancer studied by PET.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2003, v. 30, n. 1, p. 72, doi. 10.1007/s00259-002-1010-3

By:

Sutinen, Eija;
Jyrkkiö, Sirkku;
Alanen, Kalle;
Någren, Kjell;
Minn, Heikki

Publication type:

Article

Clinical significance of nuclear DNA content in pancreatic carcinoma.

Published in:

Journal of Pathology, 1990, v. 160, n. 4, p. 313, doi. 10.1002/path.1711600407

By:

Alanen, Kalle A.;
Joensuu, Heikkl;
Klemi, Pekka J.;
Nevalainen, Timo I

Publication type:

Article

Works by Alanen, Kalle

The same endothelial receptor controls lymphocyte traffic both in vascular and lymphatic vessels.

Activating mutation (V617F) in the tyrosine kinase JAK2 is absent in locally-confined or castration-resistant prostate cancer.

Increased Expression and Altered Cellular Localization of Fibroblast Growth Factor Receptor-Like 1 (FGFRL1) Are Associated with Prostate Cancer Progression.

Metabolic Imaging of Ovarian Tumors with Carbon-11-Methionine: A PET Study.

Imaging of Uterine Carcinoma by Carbon-11-Methionine and PET.

Group IIA phospholipase A<sub>2</sub> as a prognostic marker in prostate cancer: relevance to clinicopathological variables and disease-specific mortality.

Altered expression of syndecan-1 in prostate cancer.

Elevated Group II Phospholipase A<sub>2</sub> Mass Concentration in Serum and Colonic Mucosa in Crohn's Disease.

Desmocollin expression in oral atrophic lichen planus correlates with clinical behavior and DNA content.

Regulation of prostate cell collagen receptors by malignant transformation.

Accuracy of <sup>18</sup>F-FDG PET/CT, Multidetector CT, and MR Imaging in the Diagnosis of Pancreatic Cysts: A Prospective Single-Center Study.

Functional Imaging of Localized Prostate Cancer Aggressiveness Using <sup>11</sup>C-Acetate PET/CT and <sup>11</sup>H-MR Spectroscopy.

Prebiopsy multiparametric 3T prostate MRI in patients with elevated PSA, normal digital rectal examination, and no previous biopsy.

Effect of DNA ploidy classification on prognosis in breast cancer.

Expression of cystatins, high molecular weight cytokeratin, and proliferation markers in prostatic adenocarcinoma and hyperplasia.

Increased expression of fibroblast growth factor 13 in prostate cancer is associated with shortened time to biochemical recurrence after radical prostatectomy.

Androgen receptor-interacting protein HSPBAP1 facilitates growth of prostate cancer cells in androgen-deficient conditions.

Detection of melanoma-derived cancer-testis antigen CT16 in patient sera by a novel immunoassay.

Cell Proliferation in Dimethylbenz(A)Anthracene(Dmba)- Induced rat Mammary Carcinoma Treated with Antiestrogen Toremifene.

High-Throughput Transcriptomic and RNAi Analysis Identifies AIM1, ERGIC1, TMED3 and TPX2 as Potential Drug Targets in Prostate Cancer.

Immunohistochemical study on topoisomerase IIα, Ki-67 and cytokeratin-19 in oral lichen planus lesions.

Fluorine-18-L-dihydroxyphenylalanine (<sup>18</sup>F-DOPA) positron emission tomography as a tool to localize an insulinoma or β-cell hyperplasia in adult patients.

Uptake of [N-methyl-[sup 11] C]α-methylaminoisobutyric acid in untreated head and neck cancer studied by PET.

Clinical significance of nuclear DNA content in pancreatic carcinoma.